Vitamin D is a fat-soluble vitamin that plays an important role in maintaining calcium homeostasis in the body. Vitamin D, together with calcium, promotes bone formation in children and helps maintain bone strength in adults. In children, vitamin D deficiency can cause skeletal deformities known as rickets. In adults, vitamin D deficiency can lead to osteoporosis.
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1 Recent studies suggest that higher serum levels of the main circulating form of vitamin D are associated with substantially lower incidence of breast, colorectal, and prostate cancers. 2 Studies also indicate that vitamin D deficiency may be a potential risk factor for cardiovascular diseases. Anal. Chem. 2010 Chem. , 82, 1942 Chem. -1948 10.1021/ac9026862 Not subject to U.S. Copyright. Publ. 2010 Am. Chem. Soc.
been the primary method used for measuring serum 25(OH)D, and they remain the most widely used technique. 6,7 These methods incorporate antibodies that are designed to be specific for the 25(OH)D 2 and/or 25(OH)D 3 species.
8 Liquid chromatographic methods incorporating UV or electrochemical detection have also been reported. 9 More recently, tandem mass spectrometric methods (LC-MS/MS) with high selectivity and specificity have been developed. [10] [11] [12] [13] [14] [15] [16] and are increasingly used in clinical laboratories. These methods generally utilize one or more labeled internal standards for quantification of 25(OH)D.
Potential limitations exist for all of the current methodologies. Immunoassays may suffer from nonspecific interferences due to cross-reactivity with other metabolites of vitamin D or unequal assay response to 25(OH)D 3 and 25(OH)D 2 .
6,7,11,12 Mass spectrometricbased methods may suffer from interferences arising from other species with the same masses as 25(OH)D. In particular, the presence of the 3-epimers of 25(OH)D can pose problems for LC-MS/MS methods. The 3-epimer of 25(OH)D has been identified in samples from neonates. 17 Because the mass and fragmentation patterns are the same as 25(OH)D, failure to account for these metabolites resulted in overestimation of 25(OH)D 3 and 25(OH)D 2 . 8, 17 There is a need for critically evaluated reference measurement procedures (RMPs) for serum 25(OH)D to assess the accuracy of the test methods used in the clinical laboratories. RMPs can also be used to assign the concentrations of reference materials which can be used as accuracy controls or calibrators for routine test methods. They provide means for demonstrating traceability of routine test methods and materials to higher-order reference materials. were simultaneously extracted from the serum matrix with 8 mL of hexane-ethyl acetate (50:50, volume fraction). Each sample was shaken vigorously for 10 min using a mechanical shaker to allow complete mixing. The upper hexane-ethyl acetate layer was transferred to another 50 mL centrifuge tube. Hexane-ethyl acetate extraction was repeated once more with another 8 mL of solvent by shaking for 3 min. The combined extracts were dried under nitrogen at 45°C, and the residue was reconstituted with 120 µL of methanol for LC-MS/MS analysis.
Preliminary experiments were conducted to evaluate the 25(OH)D concentrations of serum materials.
determined, the quantity of internal standard was calculated to obtain a 1:1 mass ratio.
LC-MS/MS Analysis for 25(OH)D.
Samples and calibrants were analyzed with an Applied Biosystems API 4000 LC-MS/ MS system equipped with an Agilent 1100 series LC system. An isocratic mobile phase consisting of 34% water, 66% methanol (volume fraction) was used with a Zorbax SB CN column 9 at 30°C and a flow rate of 1 mL/min. At the completion of each run, the column was flushed with 100% methanol for 12 min and then equilibrated at the initial conditions for 15 min. The injection volume was 10-20 µL. The autosampler tray temperature was set at 10°C to preserve the samples. The curtain gas and collision gas were nitrogen at settings of 276 kPa (40 psi) and 21 kPa (3 psi), respectively. The ion source gas 1 and ion source gas 2 were air at settings of 483 kPa (70 psi) and 242 kPa (35 psi), respectively. The needle current was set at 5 µA, and the temperature was maintained at 350°C. The declustering potential, entrance potential, collision energy, and collision exit potential were set at 86, 10, 15, and 10 V, respectively, for 25(OH)D 3 , and at 91, 10, 13, and 12 V, respectively, for 25(OH)D 2 .
The following measurement protocol was used for LC-MS/ MS analysis. The six calibrants were analyzed along with the samples. The calibrants were analyzed first, followed by the samples, and then the samples and calibrants were analyzed in reverse order. Instrumental response was determined from a linear regression fit of the calibration data using a y ) mx + b regression model.
Method Validation for 25(OH)D.
A 25(OH)D-stripped serum was used for the 25(OH)D 3 recovery study. A commercially available frozen human serum material from a single donor containing a very small amount of 25(OH)D 2 (approximately 0.1 ng/g) was used for the 25(OH)D 2 study. The approaches described in previously published papers for steroid hormones 21, 22 were used to determine the absolute recovery of 25(OH)D 3 and 25(OH)D 2 from serum with this extraction method. The recoveries of 25(OH)D were evaluated with the serum samples that were spiked with 25(OH)D at approximately 20 ng/g. For both 25(OH)D 3 and 25(OH)D 2 , two groups of samples were prepared. For the first group, serum was spiked with 25(OH)D before extraction and the respective labeled internal standard after extraction. For the second group, both 25(OH)D and the respective labeled internal standard were spiked before extraction. The samples were processed according to the procedure described above in the sample preparation for the LC-MS/MS measurements. The absolute recovery of 25(OH)D 3 and 25(OH)D 2 from serum was calculated from the comparison of the results of the two groups.
The conditions needed for equilibration of the internal standard with serum was also studied. Commercially available frozen human serum from a single donor [containing approximately 18 ng/g 25(OH)D 3 ] was aliquoted into 12 subsamples (2 g). An appropriate amount of 25(OH)D 3 -d 3 was added to all subsamples to obtain an approximate 1:1 ratio of analyte to internal standard, The samples were equilibrated with 25(OH)D 3 -d 3 at room temperature for periods of 0.5, 1, 2, and 3 h (triplicate subsamples for each time interval) and processed as described above in the sample preparation for LC-MS/MS measurement.
The Uncertainty Evaluation. Statistical treatment of the data was in accordance with NIST guidelines, 23 which conform to the ISO Guide to the Expression of Uncertainty in Measurement. 24 Potential sources of uncertainty were evaluated, and those factors that could contribute significantly were used to calculate the standard uncertainty. For measurement imprecision uncertainty (type A component), an analysis of variance calculation was performed on the measurement data to determine if set-to-set differences were statistically significant. This analysis determined the number of independent measurements, n, used for calculating the measurement standard deviation of the mean. Other uncertainty components (type B) were based on the uncertainties in the purity of the reference compounds, in the weighing of the reference compounds, and on an allowance for unknown systematic errors in the sample preparation and undetected interferences in the LC-MS/MS analysis. Type A and type B uncertainty components were combined quadratically to determine the standard uncertainty, u c , which was multiplied by a coverage factor, k, to calculate the expanded uncertainty, U.
RESULTS AND DISCUSSION
Method Validation. To satisfy the requirements of ISO 15193, a reference measurement procedure must be thoroughly tested for sources of bias and uncertainty. Critical parameters that potentially could bias the results were tested and demonstrated below.
The time to achieve equilibration of 25(OH)D in serum with the spiked internal standard was investigated. The serum containing endogenous 25(OH)D 3 at approximately 18 ng/g was used to determine the time required for 25(OH)D to equilibrate with the internal standard, 25(OH)D-d 3 . No difference was observed among samples for the four time periods between 0.5 and 3 h. Therefore, it appears that equilibration is complete by 0.5 h. For convenience, a 1 h equilibration time was chosen.
As steroid hormones, 25(OH)D exists mainly in protein-bound forms in serum and is commonly bound with low-affinity noncovalent bonds to serum proteins. 1,21,22,25 Generally, there are two major ways to liberate the analyte from its binding protein, extreme pH (e.g., pH 2 or pH 10). 22, 25 or mechanical shaking with extraction solvents. 21 A hexane-ethyl acetate Table 3 for 25(OH)D 3 and 25(OH)D 2 , respectively. For each level, three sets of three samples were analyzed. To determine if set-to-set differences were significant, the duplicate measurements of each sample were averaged to obtain a sample mean, which was then normalized by dividing by the overall mean of 
